{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732029",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732029_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Mild\" outputclass=\"int-message\">\n  <ph otherprops=\"apalutamide\" outputclass=\"int-drug\">Apalutamide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">lansoprazole</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid or monitor</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Mild",
							"hasOrder": "1",
							"hasTextContent": "Apalutamide   is predicted to   decrease   the exposure to   lansoprazole .  Manufacturer advises avoid or monitor .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Apalutamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732030",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732030_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"atazanavir\" outputclass=\"int-drug\">atazanavir</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid or adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   decreases   the exposure to   atazanavir .  Manufacturer advises avoid or adjust dose .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atazanavir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732031",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732031_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"bosutinib\" outputclass=\"int-drug\">bosutinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   is predicted to   decrease   the absorption of   bosutinib .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bosutinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732032",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732032_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"ceritinib\" outputclass=\"int-drug\">ceritinib</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   is predicted to   decrease   the absorption of   ceritinib .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ceritinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732033",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732033_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-magnitude\">slightly to moderately</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"dasatinib\" outputclass=\"int-drug\">dasatinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   is predicted to   slightly to moderately   decrease   the exposure to   dasatinib .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dasatinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732034",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732034_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"dipyridamole\" outputclass=\"int-drug\">dipyridamole</ph> <ph outputclass=\"int-substanceQualifier\">(immediate release tablets)</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   is predicted to   decrease   the absorption of   dipyridamole   (immediate release tablets) .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dipyridamole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732035",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732035_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-magnitude\">slightly</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"erlotinib\" outputclass=\"int-drug\">erlotinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   is predicted to   slightly   decrease   the exposure to   erlotinib .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Erlotinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732036",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732036_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"gefitinib\" outputclass=\"int-drug\">gefitinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   is predicted to   decrease   the exposure to   gefitinib .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gefitinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732037",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732037_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"itraconazole\" outputclass=\"int-drug\">itraconazole</ph>. <ph outputclass=\"int-action\">Manufacturer advises administer <ph otherprops=\"itraconazole\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/itraconazole.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP3702\">itraconazole</xref></ph> capsules with an acidic beverage</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   decreases   the absorption of   itraconazole .  Manufacturer advises administer  itraconazole  capsules with an acidic beverage .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Itraconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732038",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732038_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"ketoconazole\" outputclass=\"int-drug\">ketoconazole</ph>. <ph outputclass=\"int-action\">Manufacturer advises administer <ph otherprops=\"ketoconazole\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/ketoconazole.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP8028\">ketoconazole</xref></ph> with an acidic beverage</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   decreases   the absorption of   ketoconazole .  Manufacturer advises administer  ketoconazole  with an acidic beverage .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ketoconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732039",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732039_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"ledipasvir\" outputclass=\"int-drug\">ledipasvir</ph>. <ph outputclass=\"int-action\">Manufacturer advises adjust dose, see <xref format=\"dita\" href=\"drug/ledipasvir-with-sofosbuvir.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP108187\">ledipasvir with sofosbuvir</xref></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   is predicted to   decrease   the exposure to   ledipasvir .  Manufacturer advises adjust dose, see  ledipasvir with sofosbuvir .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ledipasvir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732040",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732040_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the clearance of</ph> <ph otherprops=\"methotrexate\" outputclass=\"int-drug\">methotrexate</ph> <ph outputclass=\"int-substanceQualifier\">(high-dose)</ph>. <ph outputclass=\"int-action\">Manufacturer advises use with caution or avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   decreases   the clearance of   methotrexate   (high-dose) .  Manufacturer advises use with caution or avoid .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Methotrexate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732041",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732041_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"pazopanib\" outputclass=\"int-drug\">pazopanib</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid or administer concurrently without food</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   is predicted to   decrease   the exposure to   pazopanib .  Manufacturer advises avoid or administer concurrently without food .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pazopanib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732042",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732042_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"posaconazole\" outputclass=\"int-drug\">posaconazole</ph> <ph outputclass=\"int-substanceQualifier\">(oral suspension)</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   decreases   the absorption of   posaconazole   (oral suspension) .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Posaconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732043",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732043_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"rilpivirine\" outputclass=\"int-drug\">rilpivirine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   is predicted to   decrease   the exposure to   rilpivirine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rilpivirine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732044",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732044_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"saquinavir\" outputclass=\"int-drug\">saquinavir</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   increases   the exposure to   saquinavir .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Saquinavir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732045",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732045_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"sofosbuvir\" outputclass=\"int-drug\">sofosbuvir</ph>. <ph outputclass=\"int-action\">Manufacturer advises adjust dose, see <xref format=\"dita\" href=\"drug/ledipasvir-with-sofosbuvir.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP108187\">ledipasvir with sofosbuvir</xref>, <xref format=\"dita\" href=\"drug/sofosbuvir-with-velpatasvir.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP213021\">sofosbuvir with velpatasvir</xref>, and <xref format=\"dita\" href=\"drug/sofosbuvir-with-velpatasvir-and-voxilaprevir.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP215871\">sofosbuvir with velpatasvir and voxilaprevir</xref></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   potentially   decreases   the exposure to   sofosbuvir .  Manufacturer advises adjust dose, see  ledipasvir with sofosbuvir ,  sofosbuvir with velpatasvir , and  sofosbuvir with velpatasvir and voxilaprevir .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sofosbuvir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732046",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732046_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"tipranavir\" outputclass=\"int-drug\">Tipranavir</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">lansoprazole</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Tipranavir   decreases   the exposure to   lansoprazole .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tipranavir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732047",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732047_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"velpatasvir\" outputclass=\"int-drug\">velpatasvir</ph>. <ph outputclass=\"int-action\">Manufacturer advises adjust dose, see <xref format=\"dita\" href=\"drug/sofosbuvir-with-velpatasvir.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP213021\">sofosbuvir with velpatasvir</xref></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   is predicted to   decrease   the concentration of   velpatasvir .  Manufacturer advises adjust dose, see  sofosbuvir with velpatasvir .    \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Velpatasvir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732048",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2#bnf_i1557280732048_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lansoprazole\" outputclass=\"int-heading-drug\">Lansoprazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"voxilaprevir\" outputclass=\"int-drug\">voxilaprevir</ph>. <ph outputclass=\"int-action\">Manufacturer advises adjust dose, see <xref format=\"dita\" href=\"drug/sofosbuvir-with-velpatasvir-and-voxilaprevir.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP215871\">sofosbuvir with velpatasvir and voxilaprevir</xref></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lansoprazole   is predicted to   decrease   the exposure to   voxilaprevir .  Manufacturer advises adjust dose, see  sofosbuvir with velpatasvir and voxilaprevir .    \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Voxilaprevir</title>"
					}
				}
			],
			"hasSearchLabel": " Lansoprazole  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/lansoprazole-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Lansoprazole </title>"
			},
			"rdfs:label": "lansoprazole"
		}
	]
}